POLR2I, also known as the RNA polymerase II subunit I, is an integral component of the RNA polymerase II complex, which is pivotal in the transcription of DNA into messenger RNA (mRNA) in eukaryotic cells. This process is fundamental to the expression of genes and, consequently, to the synthesis of proteins necessary for a myriad of cellular functions and processes. POLR2I plays a specific role within the polymerase complex, contributing to its structural integrity and functional efficiency. The precise function of POLR2I, though less understood in comparison to other subunits, is believed to be critical in the assembly and stabilization of the RNA polymerase II complex, ensuring that the transcription machinery is correctly positioned and activated at gene promoters for the initiation of transcription.
The activation of POLR2I, and by extension, the RNA polymerase II complex, involves a series of well-coordinated events that facilitate the transition from transcriptional initiation to elongation. This activation process is tightly regulated by a network of signaling pathways that converge on the phosphorylation of the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II. Phosphorylation acts as a key regulatory mechanism, altering the conformation of the polymerase complex to engage with various transcription factors and mediators. Specifically, the dynamic phosphorylation and dephosphorylation of the CTD serve to recruit transcriptional machinery components, release the complex from promoter-proximal pausing, and facilitate the transition into productive elongation. Kinases and phosphatases, responsive to cellular signals, modulate these phosphorylation events, thus controlling the activation state of POLR2I within the polymerase II complex. Through these mechanisms, POLR2I participates in the finely tuned regulation of gene expression, responding to an array of developmental cues, environmental stimuli, and cellular needs, highlighting its essential role in the complex web of cellular function and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, TSA can enhance POLR2I activity by altering chromatin structure, thereby influencing transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, can affect transcription regulation, potentially enhancing POLR2I's role in mRNA synthesis. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
A CDK9 inhibitor, can influence POLR2I activity by modulating transcription elongation processes controlled by RNA polymerase II. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, can alter chromatin structure, potentially enhancing POLR2I's function in transcription. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits initiation of translation, could indirectly affect POLR2I by modulating cellular protein synthesis and related pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
A protein synthesis inhibitor, could indirectly affect POLR2I activity by influencing cellular regulatory mechanisms of transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
A topoisomerase I inhibitor, can indirectly affect POLR2I activity by altering the DNA topology and transcription process. | ||||||